首页> 外文期刊>International journal of gynecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics >High-risk human papillomavirus infection in the prediction of poor treatment response and disease recurrence in patients with vulvovaginal condyloma
【24h】

High-risk human papillomavirus infection in the prediction of poor treatment response and disease recurrence in patients with vulvovaginal condyloma

机译:高危型人乳头瘤病毒感染可预测外阴阴道尖锐湿疣患者的不良治疗反应和疾病复发

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To determine the predictive factors for progression and recurrence of vulvovaginal condyloma (WC), with a specific focus on high-risk HPV (HR-HPV) infections. Methods: Retrospective data were collected from 48 patients who were diagnosed with WC and treated with topical trichloroacetic acid application or laser therapy during 2003-2014 at a hospital in South Korea. The diagnoses were made based on the presence of exophytic condylomatous lesions as assessed by direct visual inspection regardless of whether a biopsy was performed. Results: Overall, 18 patients (50.0% of those with a test result) were positive for HR-HPV. Three-quarters of the patients with a poor treatment response had abnormal cytologies, and abnormal cytology was a risk factor for a poor response (odds ratio, 4.33 [95% confidence interval, 1.05-17.84]). During a median follow-up of 24 months, WC recurred in seven (14.6%) patients. A high viral load (more than 50 relative light units) of HR-HPV was significantly associated with recurrence (odds ratio, 7.42, 95% confidence interval, 1.19-46.18). Conclusion: A high HR-HPV load is a risk factor for recurrence, but is not related to treatment response. A poor treatment response is more related to abnormal cytology than it is to viral load. (C) 2015 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
机译:目的:确定外阴阴道尖锐湿疣(WC)的进展和复发的预测因素,特别关注高危HPV(HR-HPV)感染。方法:回顾性收集2003年至2014年在韩国一家医院接受48例确诊为WC并经局部三氯乙酸治疗或激光治疗的患者的资料。诊断的依据是通过直接肉眼检查评估是否存在外生性dy突病变,而不管是否进行了活检。结果:总体上,有18例患者(占检测结果的50.0%)的HR-HPV阳性。四分之三的治疗反应不良的患者细胞学异常,细胞学异常是反应不良的危险因素(赔率,4.33 [95%置信区间,1.05-17.84])。在24个月的中位随访期间,有7例(14.6%)患者复发WC。高病毒载量(超过50个相对轻单位)的HR-HPV与复发显着相关(优势比,7.42,95%置信区间,1.14-46.18)。结论:高的HR-HPV负荷是复发的危险因素,但与治疗反应无​​关。较差的治疗反应与细胞学异常有关,而不是与病毒载量有关。 (C)2015年国际妇产科联合会。由Elsevier Ireland Ltd.发布。保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号